Joinn Laboratories (China) Co (SHSE:603127) EBIT per Share : ¥-0.05 (TTM As of Mar. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Joinn Laboratories (China) Co EBIT per Share?

Joinn Laboratories (China) Co's EBIT per Share for the three months ended in Mar. 2024 was ¥-0.39. Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2024 was ¥-0.05.

During the past 12 months, the average EBIT per Share Growth Rate of Joinn Laboratories (China) Co was -18.00% per year. During the past 3 years, the average EBIT per Share Growth Rate was 20.50% per year. During the past 5 years, the average EBIT per Share Growth Rate was 37.20% per year. During the past 10 years, the average EBIT per Share Growth Rate was 32.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Joinn Laboratories (China) Co's EBIT per Share or its related term are showing as below:

SHSE:603127' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: 17.5 Med: 39.1 Max: 90.7
Current: 20.5

During the past 12 years, the highest 3-Year average EBIT per Share Growth Rate of Joinn Laboratories (China) Co was 90.70% per year. The lowest was 17.50% per year. And the median was 39.10% per year.

SHSE:603127's 3-Year EBIT Growth Rate is ranked better than
76.88% of 173 companies
in the Medical Diagnostics & Research industry
Industry Median: -2.2 vs SHSE:603127: 20.50

Joinn Laboratories (China) Co's EBIT for the three months ended in Mar. 2024 was ¥-292 Mil.

Joinn Laboratories (China) Co EBIT per Share Historical Data

The historical data trend for Joinn Laboratories (China) Co's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Joinn Laboratories (China) Co EBIT per Share Chart

Joinn Laboratories (China) Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EBIT per Share

Get a 7-Day Free Trial

0.35

0.58

0.88

1.65

0.68

Joinn Laboratories (China) Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EBIT per Share	Get a 7-Day Free Trial															0.29	-0.18	0.37	0.15	-0.39

Joinn Laboratories (China) Co EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Joinn Laboratories (China) Co's EBIT per Share for the fiscal year that ended in Dec. 2023 is calculated as

	EBIT per Share		(A: Dec. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	510.006	/	749.043
=	0.68

Joinn Laboratories (China) Co's EBIT per Share for the quarter that ended in Mar. 2024 is calculated as

	EBIT per Share		(Q: Mar. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-292.477	/	756.174
=	-0.39

EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-0.05

Joinn Laboratories (China) Co (SHSE:603127) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Joinn Laboratories (China) Co EBIT per Share Related Terms

Thank you for viewing the detailed overview of Joinn Laboratories (China) Co's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Joinn Laboratories (China) Co (SHSE:603127) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Joinn Laboratories (China) Co Ltd (SHSE:603127) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

06127:Hong Kong

Address

A5 Rongjing East Street, Beijing Economic-Technological Development Area, Beijing, CHN, 100176

Website

https://www.joinnlabs.com

Joinn Laboratories (China) Co Ltd is a non-clinical contract research organization(CRO) focused on drug safety assessment. It operates in three segments: Non-clinical studies services include drug safety assessment, drug metabolism & pharmacokinetics (DMPK) studies, & pharmacology & efficacy studies; Clinical trial & related services segment provides early-stage services such as clinical CRO services, co-managed phase I clinical research units, & bioanalytical services, and: Sales of research models engages in the design, production, breeding, & sales of research models, currently including non-human primates and rodents. The majority is from the Non- Clinical studies services. Its geographical segments are China, the United States, and Other countries, of which the majority is from China.

Joinn Laboratories (China) Co (SHSE:603127) Headlines

No Headlines